Soluventis Nanotherapeutics is a US-German biotechnology firm focused on the development of a proprietary Nanocarrier platform technology for the reliable systemic delivery of nucleic acids into virtually all tissues, including tumors and metastases. This technology enables the development of highly specific future RNA-based therapeutics.